Prostate cancer: Relative effects of demographic, clinical, histologic, and MR imaging variables on the accuracy of staging

被引:19
作者
Getty, DJ
Seltzer, SE
Tempany, CMC
Pickett, RM
Swets, JA
McNeil, BJ
机构
[1] BBN SYST & TECHNOL CORP, 10 MOULTON ST, CAMBRIDGE, MA 02138 USA
[2] BRIGHAM & WOMENS HOSP, DEPT RADIOL, BOSTON, MA 02115 USA
[3] HARVARD UNIV, SCH MED, DEPT HLTH CARE POLICY, BOSTON, MA 02115 USA
关键词
prostate; MR; neoplasms; receiver operating characteristic curve (ROC);
D O I
10.1148/radiology.204.2.9240538
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
PURPOSE: To determine the effects on the accuracy of staging prostate gland cancer of diagnostic prediction rules based on demographic, clinical, histologic, and magnetic resonance (MR) image variables. MATERIALS AND METHODS: A total of 200 cases from four medical centers were evaluated by nine radiologists experienced in MR imaging. The accuracies of the four diagnostic variables (age, prostate specific antigen level, Gleason tumor grade, and MR imaging findings) were measured, both singly and combined in a particular sequence, by calculating the area index of the receiver operating characteristic curve. RESULTS: The accuracy of staging with single variables (age, 0.58; prostate specific antigen level, 0.74; Gleason grade 0.73, MR image findings, 0.74) increased as the variables were optimally merged. The first two variables combined to yield an accuracy of 0.74; the first three combined to yield an accuracy of 0.81; and all four variables resulted in an accuracy of 0.86. In a clinically important subset of 69 cases for which antigen level and Gleason grade together were inconclusive for the purposes of staging, the addition of MR imaging findings resulted in an increase in accuracy from 0.55 to 0.73. CONCLUSION: Optimal merging of diagnostic test results yields an improvement in the accuracy of prostate cancer staging.
引用
收藏
页码:471 / 479
页数:9
相关论文
共 14 条
  • [1] DAMICO AV, 1995, CANCER, V75, P2368, DOI 10.1002/1097-0142(19950501)75:9<2368::AID-CNCR2820750929>3.0.CO
  • [2] 2-#
  • [3] A MULTIVARIATE-ANALYSIS OF CLINICAL AND PATHOLOGICAL FACTORS THAT PREDICT FOR PROSTATE-SPECIFIC ANTIGEN FAILURE AFTER RADICAL PROSTATECTOMY FOR PROSTATE-CANCER
    DAMICO, AV
    WHITTINGTON, R
    MALKOWICZ, SB
    SCHULTZ, D
    SCHNALL, M
    TOMASZEWSKI, JE
    WEIN, A
    [J]. JOURNAL OF UROLOGY, 1995, 154 (01) : 131 - 138
  • [4] A MULTIVARIABLE ANALYSIS OF CLINICAL FACTORS PREDICTING FOR PATHOLOGICAL FEATURES ASSOCIATED WITH LOCAL FAILURE AFTER RADICAL PROSTATECTOMY FOR PROSTATE-CANCER
    DAMICO, AV
    WHITTINGTON, R
    MALKOWICZ, SB
    SCHNALL, M
    TOMASZEWSKI, J
    SCHULTZ, D
    KAO, G
    VANARSDALEN, K
    WEIN, A
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (02): : 293 - 302
  • [5] KAI1, A METASTASIS SUPPRESSOR GENE FOR PROSTATE-CANCER ON HUMAN-CHROMOSOME 11P11.2
    DONG, JT
    LAMB, PW
    RINKERSCHAEFFER, CW
    VUKANOVIC, J
    ICHIKAWA, T
    ISAACS, JT
    BARRETT, JC
    [J]. SCIENCE, 1995, 268 (5212) : 884 - 886
  • [6] Efron B., 1982, SOC IND APPL MATH CB, V38
  • [8] THE USE OF PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE AND GLEASON SCORE TO PREDICT PATHOLOGICAL STAGE IN MEN WITH LOCALIZED PROSTATE-CANCER
    PARTIN, AW
    YOO, J
    CARTER, HB
    PEARSON, JD
    CHAN, DW
    EPSTEIN, JI
    WALSH, PC
    [J]. JOURNAL OF UROLOGY, 1993, 150 (01) : 110 - 114
  • [9] Endo-rectal coil magnetic resonance imaging in clinically localized prostate cancer: Is it accurate?
    Perrotti, M
    Kaufman, RP
    Jennings, TA
    Thaler, HT
    Soloway, SM
    Rifkin, MD
    Fisher, HAG
    [J]. JOURNAL OF UROLOGY, 1996, 156 (01) : 106 - 109
  • [10] Staging prostate cancer with MR imaging: A combined radiologist-computer system
    Seltzer, SE
    Getty, DJ
    Tempany, CMC
    Pickett, RM
    Schnall, MD
    McNeil, BJ
    Swets, JA
    [J]. RADIOLOGY, 1997, 202 (01) : 219 - 226